Blueshift Asset Management, LLC Coherus Bio Sciences, Inc. Transaction History

Blueshift Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$5.86 - $13.23 $114,123 - $257,654	-19,475 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$10.92 - $16.41 $212,667 - $319,584	19,475 New	19,475 $251,000
Q2 2021 Aug 13, 2021	SELL	$12.95 - $15.41 $414,335 - $493,042	-31,995 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$14.42 - $21.39 $461,367 - $684,373	31,995 New	31,995 $467,000
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $153,460 - $296,269	-13,150 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $214,739 - $281,015	13,150 New	13,150 $237,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blueshift Asset Management, LLC with notifications on news.